TG Therapeutics (NASDAQ:TGTX) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here’s what investors need to know before the announcement.
Analysts estimate that TG Therapeutics will report an earnings per share (EPS) of $0.34.
TG Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Overview of Past Earnings
During the last quarter, the company reported an EPS beat by $2.21, leading to a 0.36% increase in the share price on the subsequent day.
Here’s a look at TG Therapeutics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.22 | 0.30 | 0.17 | 0.08 |
| EPS Actual | 2.43 | 0.17 | 0.03 | 0.15 |
| Price Change % | 0.36 | -1.11 | -7.48 | 3.49 |
Performance of TG Therapeutics Shares
Shares of TG Therapeutics were trading at $30.51 as of February 24. Over the last 52-week period, shares are …